3,688
edits
Ketorolac: Difference between revisions
no edit summary
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
[https://pubmed.ncbi.nlm.nih.gov/10866879/ Ketorolac suppresses postoperative bladder spasms after pediatric ureteral reimplantation] | [https://pubmed.ncbi.nlm.nih.gov/10866879/ Ketorolac suppresses postoperative bladder spasms after pediatric ureteral reimplantation] | ||
Nicole A McElroy, Anna Bustin, Sarah Gattoline. Evaluation of the Safety of Ketorolac in Postsurgical Infants Less Than Six Months of Age. Pediatr Pharmacol Ther. 2022;27(4):347-351. | |||
PMID: 35558356 PMCID: PMC9088443 | |||
Stone SB. Ketorolac in Postoperative Neonates and Infants: A Systematic Review. J Pediatr Pharmacol Ther. 2021;26(3):240-247. PMID: 33833624; PMCID: PMC8021237 | |||
Ziesenitz VC, Welzel T, van Dyk M, Saur P, Gorenflo M, van den Anker JN. Efficacy and Safety of NSAIDs in Infants: A Comprehensive Review of the Literature of the Past 20 Years. Paediatr Drugs. 2022 Nov;24(6):603-655. doi: 10.1007/s40272-022-00514-1. Epub 2022 Sep 2. PMID: 36053397; PMCID: PMC9592650 | |||